CNTX

Context Therapeutics Inc. is a Boston-based late-stage biopharmaceutical company specializing in innovative non-opioid therapies aimed at managing chronic pain. With a robust pipeline that targets critical unmet medical needs, the company is well-positioned to drive advancements in pain management while prioritizing patient safety. By focusing on non-addictive solutions, Context Therapeutics is not only enhancing patient outcomes but also contributing to the broader effort to mitigate opioid dependency, thereby establishing itself as a frontrunner in the evolution of safer pain management alternatives.